Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.
about
Emergence of OXA-48-Producing Klebsiella pneumoniae in TaiwanMolecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitalsCefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.Antibiotic resistance patterns and detection of blaDHA-1 in Salmonella species isolates from chicken farms in South KoreaComparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli and Klebsiella isolates from intensive care unit patients and the utility of whole-genome sequencing in health care settingsLaboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of JapanUpdated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan.Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002IncA/C plasmid-mediated spread of CMY-2 in multidrug-resistant Escherichia coli from food animals in China.Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarityDiagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic ResistanceErtapenem pharmacokinetics and pharmacodynamics during continuous ambulatory peritoneal dialysis.Confronting bacterial resistance in healthcare settings: a crucial role for microbiologists.Molecular description of plasmid-mediated AmpC β-lactamases among nosocomial isolates of Escherichia coli & Klebsiella pneumoniae from six different hospitals in IndiaBeta-lactamase inhibitors: evolving compounds for evolving resistance targets.Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical CentersGenetic methods for detection of antimicrobial resistance.Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae.Exploring antibiotic resistance genes and metal resistance genes in plasmid metagenomes from wastewater treatment plants.New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting.Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance TrendDetection and genotype analysis of AmpC β-lactamase in Klebsiella pneumoniae from tertiary hospitals.Evidence of household transfer of ESBL-/pAmpC-producing Enterobacteriaceae between humans and dogs - a pilot study.An epidemic of plasmids? Dissemination of extended-spectrum cephalosporinases among Salmonella and other Enterobacteriaceae.National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemaseIn vitro activity of LK-157, a novel tricyclic carbapenem as broad-spectrum {beta}-lactamase inhibitor.Resistance to β-lactams in bacteria isolated from different types of Portuguese cheeseClinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli.Multiresistant Enterobacteriaceae: new threat of an old problem.Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary.AmpC beta-lactamases.A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenemsFour variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.Tackling antimicrobial resistance in lower urinary tract infections: treatment options.Antibiotic resistance in wastewater: occurrence and fate of Enterobacteriaceae producers of class A and class C β-lactamases.Patterns of resistance to beta-lactams and characterization of beta-lactamases in Escherichia coli isolates from children in Tunisia.
P2860
Q30379652-A436B325-8E90-46BE-ADEA-83F7A518EAB0Q33554703-EA5A0DE7-50B3-45CE-96E4-12458FA72714Q33598276-5E377B23-B2AA-430F-95E6-84AA10C341AAQ33938172-F7EF8630-4D15-48D0-B60B-0DB08780205BQ33983409-A14B6AE7-2822-4415-8BDF-72173744CE45Q34058030-28E5806D-E841-46F5-A724-16A6A5B314CEQ34120497-CAA2F874-F51D-4EC1-945D-BCC30F9A7316Q35071905-D0737B63-6911-4612-AB98-2AAF655430F2Q35073335-667458F7-37F3-4CD8-BF0A-63281F37B641Q35166517-D8203724-607E-405A-A909-27455C521AABQ35213565-144604D1-8E76-4DC8-8999-C61E823EF629Q35356144-30D046C5-40E2-4CF2-BA34-46B215EDC886Q35681590-E1C309DB-E640-4DD1-9FD0-3BF3CC5D3BA8Q35689411-C853F28C-735B-4D2F-98B5-0D4A9B002467Q35745242-8D7F1B8D-0CD8-4790-B2C7-3DBF8351BC79Q35838632-C86B82CA-7D0F-489C-A396-FC56E124864AQ35906971-56D0897B-237B-40E9-92C9-0F96AECF0FA5Q35912785-3A525012-5936-41AC-B443-61B4662DB891Q35993279-E5DE4F21-9AB5-4D13-A332-CDAE9C85769CQ36003062-09C76908-E4B1-43FE-8015-D7821CF34A02Q36095002-953B907E-8356-4BE2-BA26-961B00EFF3E2Q36098309-FB70EF96-6876-490A-B1AC-D53CF95A7267Q36895636-E46CE80A-A1EC-4DCA-AC34-4573F57516FCQ36969909-7BFCDAE7-A1FA-4439-A080-B60EE33C2D3EQ37001201-27BBA369-A2CE-4412-8DDE-DD833055C3CFQ37027036-4BFAAF0A-D5F5-4F8C-BC9F-65A699D50616Q37037740-5323850B-C8A4-4F44-AE1D-F0FB17AA826AQ37042604-468110E5-B6A8-4C67-889D-44DDC20CDEE9Q37072068-7D0E31C9-984C-44B3-BB1A-96CA8AD68D38Q37188234-F1018A84-BB26-437D-BBAF-FD9A904F5AC2Q37263601-A59E9CC9-EFEC-4702-B96C-389DA4EF7D84Q37291349-A5F5EC6A-EFE3-4F09-9D97-A1FD48559404Q37302749-87B9D436-2A19-4E6D-B2EC-B953C26BFA68Q37366249-5E0813DA-FEBE-4653-95D0-E7B99492AAE3Q37579796-F6B6EE56-7E28-4679-8DA5-D06C6929B15AQ37598717-418A6B7B-7490-4C7F-88BE-01E371A7285BQ38063968-6EB40EB0-35AF-46E8-8200-745B6A7A151CQ38833839-D9BE6593-4B01-4178-94CC-EE1BDE1A2C04Q39092050-86FA6417-024F-4346-BCF0-04E7610A6F0BQ39416360-57D023BB-7AD8-4BC0-BADB-50496F98780E
P2860
Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.
@en
type
label
Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.
@en
prefLabel
Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.
@en
P2093
P2860
P1476
Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.
@en
P2093
P2860
P304
P356
10.1128/AAC.48.2.533-537.2004
P407
P577
2004-02-01T00:00:00Z